NO992140L - Progesteron for behandling eller redusering av ischemi - Google Patents

Progesteron for behandling eller redusering av ischemi

Info

Publication number
NO992140L
NO992140L NO992140A NO992140A NO992140L NO 992140 L NO992140 L NO 992140L NO 992140 A NO992140 A NO 992140A NO 992140 A NO992140 A NO 992140A NO 992140 L NO992140 L NO 992140L
Authority
NO
Norway
Prior art keywords
progesterone
ischemia
reduction
treatment
Prior art date
Application number
NO992140A
Other languages
English (en)
Other versions
NO324278B1 (no
NO992140D0 (no
Inventor
Howard L Levine
William J Bologna
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24987712&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992140(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of NO992140D0 publication Critical patent/NO992140D0/no
Publication of NO992140L publication Critical patent/NO992140L/no
Publication of NO324278B1 publication Critical patent/NO324278B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19992140A 1996-11-04 1999-05-03 Anvendelse av progesteron for fremstilling av et medikament for behandling eller redusering av ischemi NO324278B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/743,153 US5985861A (en) 1996-11-04 1996-11-04 Progesterone for treating or reducing ischemia
PCT/US1997/020923 WO1998019681A1 (en) 1996-11-04 1997-11-04 Progesterone for treating or reducing ischemia

Publications (3)

Publication Number Publication Date
NO992140D0 NO992140D0 (no) 1999-05-03
NO992140L true NO992140L (no) 1999-05-04
NO324278B1 NO324278B1 (no) 2007-09-17

Family

ID=24987712

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992140A NO324278B1 (no) 1996-11-04 1999-05-03 Anvendelse av progesteron for fremstilling av et medikament for behandling eller redusering av ischemi

Country Status (27)

Country Link
US (2) US5985861A (no)
EP (1) EP0956023B1 (no)
KR (1) KR100434623B1 (no)
CN (1) CN100341512C (no)
AR (1) AR009407A1 (no)
AT (1) ATE321558T1 (no)
AU (1) AU715740C (no)
BR (1) BR9710918A (no)
CA (1) CA2270565C (no)
DE (1) DE69735598T2 (no)
DK (1) DK0956023T3 (no)
ES (1) ES2262196T3 (no)
GE (1) GEP20022630B (no)
HK (1) HK1020534A1 (no)
HU (1) HUP9904045A3 (no)
IL (1) IL127455A (no)
LV (1) LV12342B (no)
MA (1) MA24391A1 (no)
MY (1) MY121627A (no)
NO (1) NO324278B1 (no)
NZ (1) NZ335306A (no)
PE (1) PE9899A1 (no)
PT (1) PT956023E (no)
RO (1) RO120607B1 (no)
UA (1) UA66772C2 (no)
WO (1) WO1998019681A1 (no)
ZA (1) ZA979862B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056972A (en) * 1997-02-26 2000-05-02 Dimera, Llc Method for reducing coronary artery reactivity
US6602487B1 (en) 1997-02-26 2003-08-05 Dimera Incorporated Methods and tests for producing and for inhibiting coronary artery vasospasms
DE69819748T2 (de) 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
GB0107383D0 (en) * 2001-03-23 2001-05-16 Univ Edinburgh Lipid profile modulation
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US7572780B2 (en) * 2003-01-21 2009-08-11 Dimera, Incorporated Method and kit for reducing the symptoms of peripheral vascular disease
WO2004096151A2 (en) * 2003-04-29 2004-11-11 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
DE102005027004B4 (de) * 2005-06-10 2020-03-19 Continental Automotive Gmbh Scheibenwaschvorrichtung
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CA2713943C (en) * 2008-02-04 2018-10-23 Teva Women's Health, Inc. Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CA2947767A1 (en) 2014-05-22 2015-11-26 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2951284A1 (en) 2014-07-29 2016-02-04 Therapeuticsmd, Inc. Transdermal cream
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
JP2019513709A (ja) 2016-04-01 2019-05-30 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． ステロイドホルモン薬学的組成物
US11787835B2 (en) 2018-09-07 2023-10-17 Trustees Of Dartmouth College C19 scaffolds and steroids and methods of use and manufacture thereof
US11512107B2 (en) 2018-09-07 2022-11-29 Trustees Of Dartmouth College Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1124906A1 (ru) * 1982-05-25 1984-11-23 Ивановский государственный медицинский институт им.А.С.Бубнова Способ коррекции ишемических повреждений консервированной донорской почки
US4615697A (en) * 1983-11-14 1986-10-07 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof

Also Published As

Publication number Publication date
CA2270565C (en) 2007-02-20
US6054447A (en) 2000-04-25
KR100434623B1 (ko) 2004-06-05
AU5180198A (en) 1998-05-29
PT956023E (pt) 2006-08-31
HK1020534A1 (en) 2000-05-12
NO324278B1 (no) 2007-09-17
PE9899A1 (es) 1999-02-08
AR009407A1 (es) 2000-04-12
DK0956023T3 (da) 2006-08-07
UA66772C2 (uk) 2004-06-15
DE69735598D1 (de) 2006-05-18
GEP20022630B (en) 2002-02-25
CN100341512C (zh) 2007-10-10
NZ335306A (en) 2000-12-22
AU715740B2 (en) 2000-02-10
RO120607B1 (ro) 2006-05-30
MA24391A1 (fr) 1998-07-01
LV12342A (lv) 1999-09-20
KR20000053056A (ko) 2000-08-25
BR9710918A (pt) 2000-01-11
ZA979862B (en) 1998-05-25
CA2270565A1 (en) 1998-05-14
LV12342B (en) 2000-01-20
MY121627A (en) 2006-02-28
EP0956023A1 (en) 1999-11-17
NO992140D0 (no) 1999-05-03
CN1235549A (zh) 1999-11-17
US5985861A (en) 1999-11-16
WO1998019681A1 (en) 1998-05-14
IL127455A (en) 2005-03-20
HUP9904045A2 (hu) 2000-04-28
DE69735598T2 (de) 2006-12-28
ATE321558T1 (de) 2006-04-15
HUP9904045A3 (en) 2000-11-28
ES2262196T3 (es) 2006-11-16
IL127455A0 (en) 1999-10-28
AU715740C (en) 2004-04-29
EP0956023B1 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
NO992140D0 (no) Progesteron for behandling eller redusering av ischemi
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
NO986051D0 (no) Antikonvulsive derivater for behandling av manisk-depressive mangler
NO20011940L (no) Substituerte benzopyrananaloger for behandling av inflammasjon
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
NO992641D0 (no) Blandinger og fremgangsmÕter for behandling eller forhindring av betennelsessykdommer
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
IS1886B (is) Stjórnuð losun stera úr sykruhúðum
NO944919D0 (no) Fremgangsmåte for å inhibere atrofi av huden eller vagina
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
NO991460L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av seborÚisk dermatitt
NO996545L (no) Behandling av aluminiumslagg
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO992260D0 (no) Rekombinant bicistronadenovirus for behandling av patologiske tilstander forbundet med dyslipoproteinemi
NO984189D0 (no) Fremgangsmåte for behandling av bipolar forstyrrelse
NO953089L (no) Steroider for behandling av klimakterieplager
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis
NO962812D0 (no) Fremgangsmåte for behandling av nervebetennelse
NO970127D0 (no) Topiske sammensetninger for behandling av hudsykdom
DE29817647U1 (de) Behandlungskabine
NO984190D0 (no) Fremgangsmåte for behandling av insomnia
GB9603487D0 (en) 4-azasteroids for the treatment of hyperandrogenic conditions
KR980002508U (ko) 차량의 플로어사이드 패널